# Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis Patients

> **NCT00996463** · PHASE2 · COMPLETED · sponsor: **Waisenmedizin e. V. Promoting Access to Essential Medicine** · enrollment: 63 (estimated)

## Conditions studied

- Wound Healing

## Interventions

- **PROCEDURE:** Electro-thermo-coagulation
- **DRUG:** Sodium Stibogluconate
- **DRUG:** DAC N-055

## Key facts

- **NCT ID:** NCT00996463
- **Lead sponsor:** Waisenmedizin e. V. Promoting Access to Essential Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-09
- **Final completion:** 2011-03
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2011-03-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00996463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00996463, "Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis Patients". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00996463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*